NovoCure Ltd

Company Profile

• Business description

  NovoCure Ltd is an oncology company with a proprietary platform technology in the United States. Its business involves the development, manufacture, and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis, and other products and technologies for the treatment of Glioblastoma, Non-small cell lung cancer, and Pancreatic cancer. Geographically, the company derives the majority of its revenue from the United States and the rest from Germany, Japan, and other markets.

• Contact

  Grenville Street
  No. 4 The Forum, Second Floor
  St. HelierJE2 4UF
  JEY

  T: +44 1534756700

  E: [email protected]

  https://www.novocure.com

• Sector

  Healthcare

  Stock type

  Defensive

• Industry

  Medical Devices

  Fiscal Year End

  31 December 2026

  Employees

  1,605